Cancer-associated retinopathy induced by both anti-recoverin and anti- hsc70 antibodies in vivo

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 13, 1999, Pages 3160-3167

  Ohguro, Hiroshi ^a   Ogawa, Kei Ichi ^a   Maeda, Tadao ^a   Maeda, Akiko ^a   Maruyama, Ikuyo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; RECOVERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRORETINOGRAM; IMMUNOFLUORESCENCE; MODEL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RETINOPATHY;

ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CATTLE; DRUG COMBINATIONS; ELECTRORETINOGRAPHY; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HIPPOCALCIN; HSC70 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; IMMUNOGLOBULIN G; IN SITU NICK-END LABELING; LIPOPROTEINS; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES; RATS; RATS, INBRED LEW; RECOVERIN; RETINA; RETINAL DISEASES;

EID: 0032727022     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Sawyer RA, Selhorse JB, Zimmerman LE. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;90:606-613.
2. Kornguth SE, Klein R, Appen R, Choate J. Occurrence of antiretinal ganglion cell antibodies in patients with small cell cancer of the lung. Cancer. 1982;50:1289-1293.
3. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration: possible autoimmune disorder. Arch Ophthalmol. 1983;101:564-569.
4. Buchanan TAS, Gardiner TA, Archer DB. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial cancer. Am J Ophthalmol. 1984;97:277-287.
5. Klingele TG, Burde RM, Rappazzo JA, Isserman MJ, Burgess D, Kantor O. Paraneoplastic retinopathy. J Clin Neuro Ophthalmol. 1984;4:239-245.
6. Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110:48-53.
7. Thirkill CE, Keltner JL, Tyler NK, Roth AM. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol. 1993;111:931-937.
8. Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol. 1990;28:162-167.
9. Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992;33:2768-2772.
10. Polans AS, Buczylko J, Crabb J, Palczewski K. A photoreceptor calcium-binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol. 1991; 112:981-989.
11. Kawamura S. Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin. Nature. 1991; 362:855-857.
12. Ohguro H, Rudonicka-Nawrot M, Buczylko J, et al. Structural and enzymatic aspects of rhodopsin phosphorylation. J Biol Chem. 1996;271:5215-5224.
13. Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Recoverin, a photoreceptor-specific calcium-binding; protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA. 1995;92:9176-9180.
14. Yamaji Y, Matsubara S, Yamadori I, et al. Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy. Int J Cancer. 1996;65:671-676.
15. Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. Arch Ophthalmol. 1993;111:974-978.
16. Thirkill CE. Lung cancer-induced blindness. Lung Cancer. 1996; 14:253-264.
17. Thirkill CE. Experimental cancer-induced retinopathy. Ocular Immunol Inflamm. 1997;5:55-65.
18. Grunwald GB, Klein R, Simmonds MA, Kornguth SE. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell cancer. Lancet. 1985:658-661.
19. Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL. Cancer-associated retinopathy (CAR) with autoantibodies reacting with retinal optic nerve, cancer cells. N Engl J Med. 1989;321: 1589-1594.
20. Ohguro H, Ogawa K, Nakagawa T. Both recoverin and hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1999;40:82-89.
21. Adamus G, Aptsiauri N, Guy J, Heckenlively J, Flannery J, Hargrave PA. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol. 1996;78:120-129.
22. Korngruth SE, Kalinke T, Grunwald GB, Schutta H, Dahl D. Antineurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 1986;46:2588-2595.
23. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372-375.
24. Adamus G, Guy J, Schmied JL, Arendt A, Margrave PA. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:2626-2633.
25. Polans AS, Crabb J, Palczewski K. Calcium-binding proteins in the retina. Methods Neurosci. 1993;15:248-260.
26. Buczylko J, Palczewski, K. Purification of arrestin from bovine retinas. Methods Neurosci. 1993;15:226-236.
27. Milam AH, Dacey DM, Dizhoor AM. Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci. 1992;10:1-12.
28. Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I. Recoverin-associate retinopathy: a clinically and immunologically distinctive disease, Am J Ophthalmol. 1998;126:230-237.
29. Lindquist S. The heat-shock response. Annu Rev Biochem. 1986; 55:1151-1191.
30. Lindquist S, Craig EA. The heat shock proteins. Annu Rev Genet. 1988;22:631-677.
31. Hartl FU. Molecular chaperones in cellular protein folding. Nature. 1996;381:571-580.
32. Minota S, Cameron B, Welch WJ, Winfield JB. Autoantibodies to the constitutive 73-kD member of the hsp 70 family of heat shock proteins in systemic lupus erythematosus. J Exp Med. 1988;168: 1475-1480.
33. Minota S, Koyasu S, Yahara I, Weinfield JB. Autoantibodies to the heat shock protein Hsp 90 in SLE. J Clin Invest. 1988;81:106-109.
34. Jarjour W, Jeffries B, Davis J, Welch W, Miura T, Winfield JB. Autoantibodies to human stress proteins. Arthritis Rheum. 1991; 34:1133-1138.
35. Mairesse N, Kahn MF, Appelboom T. Antibodies to the constitutive 73 kDa heat shock protein: a new marker of mixed connective tissue disease. Am J Med. 1993;6:595-600.
36. Adamus G, Machnicki M, Elerding H, Sugden B, Blocker YS, Fox DA. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun. 1998;11:523-533.
37. Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1997;38:283-291.
38. Alarcon-Segovia D, Riut-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today. 1996;17:163-164.
39. Greenlee JE, Parks TN, Jaeckle KA. Type IIa (anti-Hu) antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro Neurology. 1993;43:2049-2054.
40. Robinson PR, Buczylko J, Ohguro H, Palczewski K. Opsins with mutations at the site of chromophore attachment constitutively active transducin but are not phosphorylated by rhodopsin kinase. Proc Natl Acad Sci USA. 1994;91:5411-5451.
41. Sung C-H, Davenport CM, Hennessey JC, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:6481-6485.
42. Chen J, Makino CL, Peachey NS, Baylor DA, Simon MI. Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant. Science. 1995;267:374-377.
43. Ohguro H. High levels of rhodopsin phosphorylation in missense mutations of C-terminal region of rhodopsin. FEBS Lett. 1995;413: 433-435.
44. De Castro E, Nef S, Fiumelli H, Lenz SE, Kawamura S, Nef P. Regulation of rhodopsin phosphorylation by a family of neuronal calcium sensors. Biochem Biophys Res Commun. 1995;216:133-140.
45. Chalk CH, Murray NM, Newsom-Davis J, O'Neill JH, Spiro SG. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology. 1990;40:1552-1556.
46. Anderson NE. Anti-neuronal antibodies and neurological paraneoplastic syndrome. Aust NZ J Med. 1989;19:379-387.
47. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc. 1990;65:1423-1431.
48. Keltner JL, Thirkill CE. Cancer-associated retinopathy vs. recoverin-associated retinopathy. Am J Ophthalmol. 1998;128:296-302.
49. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84:304-315.
50. Weissmann G, Sessa G, Bevans V. Effect of DMSO on the stabilization of lysosomes by cortisone and chloroquine in vivo. Ann NY Acad Sci. 1967;141:326-332.
51. Augustin AJ, Spitznas M, Secant W, et al. Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: a biochemical and morphological study. Br J Ophthalmol. 1996;80:451-457.
52. Larsson EL. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol. 1980;124:2828-2833.
53. White DJ, Calne RY. The use of cyclosporin A immunosuppression in organ grafting. Immunol Rev. 1982;65:115-131.
54. Nussenblatt RB, Rodrigues MM, Wacker WB, et al. Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest. 1981;67:1228-1231.